Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist

Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist

Bibliographic Details
Main Authors:	Rupp Matthias, Schroeter T, Steri R, Proschak Ewgenij, Hansen K, Zettl H, Rau O, Schubert-Zsilavecz M, Müller K-R, Schneider Gisbert
Format:	Article
Language:	English
Published:	BMC 2010-05-01
Series:	Journal of Cheminformatics

Similar Items

Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro
by: Pascal Heitel, et al.
Published: (2018-09-01)

PocketPicker: analysis of ligand binding-sites with shape descriptors
by: Schneider Gisbert, et al.
Published: (2007-03-01)

Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists
by: Catherine Gurley, et al.
Published: (2008-01-01)

Nutraceuticals as Ligands of PPARγ
by: Meera Penumetcha, et al.
Published: (2012-01-01)

Structural Basis for PPARs Activation by The Dual PPARα/γ Agonist Sanguinarine: A Unique Mode of Ligand Recognition
by: Siyu Tian, et al.
Published: (2021-10-01)

DOGS: reaction-driven de novo design of bioactive compounds.
by: Markus Hartenfeller, et al.
Published: (2012-01-01)

Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.
by: Vinicius G Maltarollo, et al.
Published: (2015-01-01)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01)

SBE13, a newly identified inhibitor of inactive polo-like kinase 1
by: Keppner Sarah, et al.
Published: (2010-05-01)

PPARγ Agonists: Blood Pressure and Edema
by: Bonnie L. Blazer-Yost
Published: (2010-01-01)

PPARγ Agonists: Emergent Therapy in Endometriosis
by: Alexandre Vallée, et al.
Published: (2021-06-01)

Effects of PPARγ Ligands on Leukemia
by: Yoko Tabe, et al.
Published: (2012-01-01)

Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.
by: Li-Song Zhang, et al.
Published: (2012-01-01)

Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in human hepatocytes.
by: Alexandra Rogue, et al.
Published: (2011-01-01)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
by: Nordsletten Lars, et al.
Published: (2009-03-01)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
by: Tamotsu Tsukahara
Published: (2012-01-01)

PPARγ and Its Agonists in Chronic Kidney Disease
by: Yuhua Ma, et al.
Published: (2020-01-01)

PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
by: Sarawin Harnchoowong, et al.
Published: (2017-01-01)

Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
by: Hayley Patricia Ellis, et al.
Published: (2014-03-01)

Lipid metabolome-wide effects of the PPARγ agonist rosiglitazones⃞
by: Steven M. Watkins, et al.
Published: (2002-11-01)

Clinical Use of PPARγ Ligands in Cancer
by: Jennifer L. Hatton, et al.
Published: (2008-01-01)

Different Coactivator Recruitment to Human PPARα/δ/γ Ligand-Binding Domains by Eight PPAR Agonists to Treat Nonalcoholic Fatty Liver Disease
by: Shotaro Kamata, et al.
Published: (2024-03-01)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
by: Zhanjun Jia, et al.
Published: (2014-01-01)

Dual PPAR α/γ agonists: Continuing cardiac concerns
by: Karthik Balach
Published: (2019-01-01)

Synthesis of Phthalimide Derivatives as Potential PPAR-γ Ligands
by: So Hyeon Eom, et al.
Published: (2016-06-01)

PPARα/γ-Independent Effects of PPARα/γ Ligands on Cysteinyl Leukotriene Production in Mast Cells
by: Masamichi Yamashita
Published: (2008-01-01)

Importance of the Proximity and Orientation of Ligand-Linkage to the Design of Cinnamate-GW9662 Hybrid Compounds as Covalent PPARγ Agonists
by: Yuki Utsugi, et al.
Published: (2019-05-01)

PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer
by: A. Belfiore, et al.
Published: (2009-01-01)

Regulation of Glial Cell Functions by PPAR-𝜸 Natural and Synthetic Agonists
by: Antonietta Bernardo, et al.
Published: (2008-01-01)

Antidiabetic Effect of Dihydrobetulonic Acid Derivatives as Pparα/γ Agonists
by: Mikhail V. Khvostov, et al.
Published: (2024-12-01)

The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria
by: Lena Serghides
Published: (2012-01-01)

Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists
by: Jeremy P. McAleer
Published: (2023-03-01)

Optimized Structure-based Methodology for Studying PPARγ Partial Agonists
by: Merilin Al Sharif, et al.
Published: (2018-03-01)

Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts
by: Jun Bon Koo, et al.
Published: (2017-06-01)

The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
by: Swanson Christine R, et al.
Published: (2011-08-01)

Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
by: Masahito Shimizu, et al.
Published: (2008-01-01)

Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists
by: Yves Lecarpentier, et al.
Published: (2019-05-01)

Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
by: P. J. Simpson-Haidaris, et al.
Published: (2010-01-01)

Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARα+γ Agonists
by: Martin B. Oleksiewicz, et al.
Published: (2008-01-01)

Ciglitazone—a human PPARγ agonist—disrupts dorsoventral patterning in zebrafish
by: Vanessa Cheng, et al.
Published: (2019-11-01)